Azelis strengthens its portfolio in India with a recognised pharmaceutical lactose range for oral solid dosage formulations.

INDIA – Azelis has announced a new distribution partnership with Lactalis for the Pharmaceuticals & Healthcare market in India.
Azelis will distribute the Lactalpha pharmaceutical lactose range across India, further strengthening its portfolio for oral solid dosage formulations.
Customers in India will gain access to the Lactalpha range of high-quality milled and sieved pharmaceutical lactose, expanding their excipient options for oral formulations.
Lactalis expands its reach within the Indian pharmaceutical market through Azelis’s established customer network, technical expertise, application support, and strong local presence built over 75 years in India.
Nicolas Barachon, Business Development Director Pharmaceutical Lactose, Lactalis, said, “India is an important market for Lactalis’s pharmaceutical lactose business, and we were looking for a partner with strong local market knowledge, technical capabilities, and established customer relationships in the pharmaceutical sector. Through this partnership with Azelis, we aim to expand access to the Lactalpha range and support customers with reliable, high-quality lactose solutions for oral solid dosage applications.”
The Lactalpha range includes milled and sieved low-nitrite lactose suitable for wet and dry granulation, as well as dry-blending production. It is suitable for oral solid dosage forms such as tablets, sachets, and capsules and is compliant with Ph. Eur., USP-NF, and JP standards.
Aparna Khurana, Managing Director India and Market Segment Director Personal Care and Home Care & Industrial Cleaning APAC, Azelis, shared: “We are pleased to partner with Lactalis to strengthen our Pharma & Healthcare portfolio in India. Lactalis’s pharmaceutical lactose expertise, combined with Azelis’s strong customer relationships, technical support, and local presence, will deliver enhanced value and formulation support to customers across the Indian pharmaceutical industry.”
Azelis’s innovation capabilities are driven by the deep technical expertise of its teams across EMEA, the Americas, and Asia Pacific.
The group combines market trends with ingredient expertise and formulation know-how to develop innovative solutions. With this, it inspires and supports its partners in developing new, sustainable products efficiently.
Through close collaboration between technical, sales, marketing, and business development specialists, Azelis translates ideas towards ready-to-launch concepts and is dedicated to staying ahead of customer-specific developments, pushing the boundaries of what’s possible in innovation to support its customers in their business development journey.
To receive our email newsletters with the latest news and insights from Africa, the Middle East and around the world, SUBSCRIBE HERE
Be the first to leave a comment